Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of artery | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of SSTR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 90% | 1615.23 | 323 / 359 | 75% | 7.87 | 214 / 286 |
pancreas | 94% | 234.89 | 307 / 328 | 70% | 9.36 | 125 / 178 |
prostate | 77% | 208.47 | 189 / 245 | 84% | 18.62 | 422 / 502 |
liver | 100% | 708.62 | 225 / 226 | 57% | 6.60 | 232 / 406 |
brain | 86% | 753.84 | 2264 / 2642 | 64% | 11.17 | 453 / 705 |
intestine | 72% | 374.56 | 698 / 966 | 76% | 7.82 | 398 / 527 |
lung | 100% | 1006.39 | 576 / 578 | 31% | 3.13 | 361 / 1155 |
bladder | 100% | 397.57 | 21 / 21 | 23% | 1.69 | 118 / 504 |
kidney | 69% | 158.06 | 61 / 89 | 48% | 3.21 | 436 / 901 |
uterus | 86% | 212.22 | 147 / 170 | 17% | 2.09 | 77 / 459 |
breast | 75% | 192.82 | 344 / 459 | 3% | 0.46 | 35 / 1118 |
esophagus | 31% | 56.44 | 450 / 1445 | 41% | 10.56 | 75 / 183 |
blood vessel | 70% | 172.91 | 934 / 1335 | 0% | 0 | 0 / 0 |
adipose | 69% | 167.92 | 833 / 1204 | 0% | 0 | 0 / 0 |
ovary | 65% | 147.25 | 117 / 180 | 2% | 0.14 | 8 / 430 |
adrenal gland | 8% | 14.67 | 21 / 258 | 50% | 14.42 | 114 / 230 |
heart | 52% | 83.15 | 444 / 861 | 0% | 0 | 0 / 0 |
skin | 41% | 408.86 | 733 / 1809 | 1% | 0.08 | 4 / 472 |
thymus | 33% | 49.99 | 218 / 653 | 2% | 0.07 | 13 / 605 |
spleen | 29% | 37.83 | 69 / 241 | 0% | 0 | 0 / 0 |
muscle | 11% | 14.07 | 89 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.42 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021549 | Biological process | cerebellum development |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0038170 | Biological process | somatostatin signaling pathway |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0007283 | Biological process | spermatogenesis |
GO_0007215 | Biological process | glutamate receptor signaling pathway |
GO_0042594 | Biological process | response to starvation |
GO_0030900 | Biological process | forebrain development |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0005886 | Cellular component | plasma membrane |
GO_0043005 | Cellular component | neuron projection |
GO_0042923 | Molecular function | neuropeptide binding |
GO_0004994 | Molecular function | somatostatin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SSTR1 |
Protein name | Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R) (SST1) (SRIF-2) |
Synonyms | |
Description | FUNCTION: Receptor for somatostatin with higher affinity for somatostatin-14 than -28. This receptor is coupled via pertussis toxin sensitive G proteins to inhibition of adenylyl cyclase. In addition it stimulates phosphotyrosine phosphatase and Na(+)/H(+) exchanger via pertussis toxin insensitive G proteins. |
Accessions | ENST00000267377.3 P30872 |